최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Biochemical and biophysical research communications, v.494 no.3/4, 2017년, pp.674 - 680
Yang, Ji-peng (Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China) , Yang, Jian-kai (Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China) , Li, Chen (Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China) , Cui, Zhi-qiang (Graduate College of Hebei Medical University, Shijiazhuang, People’s Republic of China) , Liu, Hong-jiang (Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China) , Sun, Xiao-feng (Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China) , Geng, Shao-mei (Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China) , Lu, Sheng-kui (Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China) , Song, Jian (Department of Neurosurgery, The Second Hospital of Hebe) , Guo, Cheng-yong , Jiao, Bao-hua
Abstract ZMYND11 (zinc finger MYND-type containing 11) has been widely regarded to be involved in a variety of cancers as a potential suppressor. However, the biological role and mechanism of ZMYND11 in glioblastoma multiform (GBM) remain unknown. In this study, we found that ZMYND11 expression was...
J. Neurol. Sci. Rigamonti 378 3 2017 10.1016/j.jns.2017.04.030 Pattern of care and outcome in elderly patients with glioblastoma: data in 151 patients from 3 Lombardia Hospitals
Neurosurgery Esquenazi 81 275 2017 10.1093/neuros/nyw174 The survival advantage of “supratotal” resection of glioblastoma using selective cortical mapping and the subpial technique
Nature Wen 508 263 2014 10.1038/nature13045 ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression
Biochem. Biophys. Res. Commun. Hetey 490 868 2017 10.1016/j.bbrc.2017.06.133 Biophysical characterization of histone H3.3 K27M point mutation
Proc. Natl. Acad. Sci. U. S. A. Lan 112 22 6814 2015 10.1073/pnas.1418996111 Histone H3.3 and cancer: a potential reader connection
J. Biol. Chem. Ansieau 277 4906 2002 10.1074/jbc.M110078200 The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif
Oncogene Ladendorff 20 125 2001 10.1038/sj.onc.1204048 BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb
Ups. J. Med. Sci. Swartling 117 122 2012 10.3109/03009734.2012.658975 Myc proteins in brain tumor development and maintenance
Acta Neuropathol. Shindo 86 345 1993 10.1007/BF00369446 Stabilization of c-myc protein in human glioma cells
Mol. Cell Biochem. Shervington 283 1 2006 10.1007/s11010-006-2495-z Glioma: what is the role of c-Myc, hsp90 and telomerase?
Int. Rev. Cell Mol. Biol. Mercatelli 333 269 2017 10.1016/bs.ircmb.2017.03.002 MicroRNAs as multifaceted players in glioblastoma multiforme
Mol. Biosyst. Wang 13 1345 2017 10.1039/C7MB00139H Tumor suppressors microRNA-302d and microRNA-16 inhibit human glioblastoma multiforme by targeting NF-κB and FGF2
Oncotarget Chen 7 9222 2016 10.18632/oncotarget.7003 MiR-129 triggers autophagic flux by regulating a novel Notch-1/E2F7/Beclin-1 axis to impair the viability of human malignant glioma cells
Clin. Cancer Res. Guan 16 4289 2010 10.1158/1078-0432.CCR-10-0207 MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance
Nature Wen 508 263 2014 10.1038/nature13045 ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression
Genes (Basel) Hutter 8 E107 2017 10.3390/genes8040107 Modeling and targeting myc genes in childhood brain tumors
PLoS One Wang 3 3769 2008 10.1371/journal.pone.0003769 c-Myc is required for maintenance of glioma cancer stem cells
Jpn. J. Clin. Oncol. Huang 20 1 2017 Up-regulated microRNA-299 corrected with poor prognosis of glioblastoma multiforme patients by targeting ELL2
Cell Biochem. Funct. Dong 35 260 2017 10.1002/cbf.3271 MiR-429 suppresses glioblastoma multiforme by targeting SOX2
J. Neurooncol Chen 133 477 2017 10.1007/s11060-017-2463-3 MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor
Biochem. Biophys. Res. Commun. Huang 486 1129 2017 10.1016/j.bbrc.2017.04.008 Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme
Eur. Rev. Med. Pharmacol. Sci. Li 21 2840 2017 MiR-130b functions as a tumor promoter in glioma via regulation of ERK/MAPK pathway
Artif. Cells Nanomed Biotechnol. Xue 1 2017 MicroRNA-133b expression associates with clinicopathological features and prognosis in glioma
World J. Gastroenterol. Schimanski 15 2089 2009 10.3748/wjg.15.2089 High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells
Neuro Oncol. Yang 16 652 2014 10.1093/neuonc/not307 MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo
※ AI-Helper는 부적절한 답변을 할 수 있습니다.